Extranodal NK-T-cell lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
Replaced content with "__NOTOC__ {{Extranodal NK-T-cell lymphoma}} {{CMG}}; {{AE}} {{RG}} {{AS}} ==Overview==" Tag: Replaced |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{RG}} {{AS}} | {{CMG}}; {{AE}} {{RG}} {{AS}} | ||
==Overview== | ==Overview== | ||
Revision as of 15:18, 16 August 2019
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics |
FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics |
CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Extranodal NK-T-cell lymphoma epidemiology and demographics in the news |
Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]